NCT06112574

Brief Summary

Stroke is a leading and growing cause of long-term adult disability. Up to 80% of stroke patients have impaired manual dexterity reducing their independence, return to work and quality of life. Cognitive impairment is also common after stroke and growing evidence suggests a cognitive-motor interdependence with relevance for motor recovery. Previous studies show increased cognitive-motor interference (measured in dual-task) in stroke patients and that combining motor and cognitive task training (in a dual-task) may improve motor function above that achieved by single-task training. This project addresses post-stroke dexterity impairment and its relation to dual-task interference, i.e., the decrease in motor performance when performing a concurrent cognitive task. The overall goal is to provide a proof-of-concept for a dual-task interference training protocol post-stroke. We aim to establish therapeutic efficacy of dual-task vs single-task dexterity training in chronic stroke patients.Single-task training involves visuomotor finger force tracking and dual-task has an additional cognitive components including visual distraction and working memory. Training will be done 4 days/week over four weeks (total 16 sessions). Each session will include 20 mins of conventional therapy (stretching, functional exercises) followed by 40 mins motor task training (either single or dual task). This pilot randomized clinical trial will include 40 stroke patients (\> 6 months after stroke). Repeated clinical and fine-grained motor measurements will be obtained pre and post intervention and at 3 months follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 1, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

September 11, 2023

Last Update Submit

October 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment change (FMA change)

    Assesses sensory and movement related functions in the upper extremity (0 points max impairment summed up to 66 points max no detected impairment)

    At baseline and at 3 to assess change.

Secondary Outcomes (4)

  • Box and Block change (BBT change)

    At baseline and at 3 to assess change.

  • Logical reasoning change (WAIS IV matrices change)

    At baseline and at 3 to assess change.

  • Attention change (D-KEFS trail making test 1-5)

    [At baseline and at 3 to assess change.

  • Executive function change (D-KEFS FAS, D-KEFS tower)

    At baseline and at 3 to assess change.

Study Arms (2)

Single-task

ACTIVE COMPARATOR

Visuomotor training

Behavioral: Visuomotor force control training

Dual-task

EXPERIMENTAL

Visuomotor + cognitive components training

Behavioral: Visuomotor force control training

Interventions

Single-task training involves visuomotor finger force tracking and dual-task has an additional cognitive components including visual distraction and working memory.

Dual-taskSingle-task

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • adults with clinical diagnosis of stroke and history of upper limb hemiparesis. Arm and hand paresis is defined as weakness according to Manual Muscle Testing (score less than 4/5 in one upper limb muscles)
  • reported difficulty in opening/closing of hand or difficulty in using the hand in daily activities

You may not qualify if:

  • inability to grasp and displace an object (minimum score of 1 on Box and Block Test, BBT)
  • impaired cognition (MOCA score \<23)
  • cerebellar stroke
  • aphasia disturbing communication and understanding of training task
  • neglect interfering with ability to see task on screen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Danderyd Hospital, Division of Rehabilitation Medicine, Dept. of Clinical Sciences, Karolinska Institutet

Stockholm, Danderyd, S18288, Sweden

Location

Department of Rehabilitation Medicine, Danderyd Hospital

Danderyd, Stockholm County, SE-18288, Sweden

Location

MeSH Terms

Conditions

Motor Skills Disorders

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2023

First Posted

November 1, 2023

Study Start

October 1, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

November 1, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations